@pep_researcher For sure, they have amazing R&D, but its the evil empire. They have done the impact analysis on peptides and determined what to bring to market that doesn't impact other medications, profit centers. They are slow rolling Reta; it's obvious. While they do the slow roll they are creating market buzz, and trying to drive up black market prices. Its all strategy.